Basic Materials / Specialty ChemicalsBSE
$51.98
-1.92 (-3.56%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 17%
FCF escenarios
weak_data · normalized FCF $-9.6M · quality 41.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
28/100
D
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$532M
P/E
22.9x
↑EV/EBITDA
12.1x
↑ROE
5.5%
↑Gross Margin
5.2%
↓Debt/Equity
0.32
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-0.9%
FCF CAGR
—
FCF margin
-1.0%
FCF / Net income
-0.47x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $952.8M · net income $20.5M · FCF $-9.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $952.8M | $952.8M | $949.1M | $853.3M | $978.4M |
| Net Income | $20.5M | $20.5M | $-2.7M | $27.9M | $25.3M |
| EBITDA | $54.0M | $54.0M | $13.1M | $59.3M | $54.5M |
| EPS | 2.01 | 2.01 | -0.27 | 2.73 | 2.47 |
| Gross Margin | 5.2% | 5.2% | 3.3% | 1.8% | 5.9% |
| Operating Margin | 3.4% | 3.4% | 1.4% | -0.2% | 3.7% |
| Net Margin | 2.2% | 2.2% | -0.3% | 3.3% | 2.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.32 | 0.32 | 0.28 | 0.36 | 0.39 |
| Cash Flow | |||||
| Free Cash Flow | $-9.6M | $-9.6M | $-178.7M | $14.3M | $-34.7M |
| Returns | |||||
| ROE | 5.5% | 5.5% | -0.8% | 9.6% | 9.8% |
| Valuation | |||||
| P/E | 22.90 | 22.90 | — | — | — |
| EV/EBITDA | 12.05 | 12.05 | — | — | — |
| P/B | 1.41 | 1.41 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | 0.4% | 0.4% | 11.2% | -12.8% | — |
| EPS Growth | 844.4% | 844.4% | -109.9% | 10.5% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
31.9%
EPS terminal req.
$4.61
Spread vs growth
812.5%
5Y implied EPS CAGR
22.7%
EPS terminal req.
$5.58
Spread vs growth
821.8%
10Y implied EPS CAGR
16.2%
EPS terminal req.
$8.99
Spread vs growth
828.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+2.6%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.27 → 2.01
Residual
+2.6%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.